How Should Investors React To UMP Healthcare Holdings Limited's (HKG:722) CEO Pay?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets open in 9 hrs 24 minsS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)How Should Investors React To UMP Healthcare Holdings Limited's (HKG:722) CEO Pay?Simply Wall StSimply Wall St.January 10, 2020ReblogShareTweetShareView photosYiu Kwong Sun has been the CEO of UMP Healthcare Holdings Limited (HKG:722) since 2015. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Next, we'll consider growth that the business demonstrates. Third, we'll reflect on the total return to shareholders over three years, as a second measure of business performance. The aim of all this is to consider the appropriateness of CEO pay levels. See our latest analysis for UMP Healthcare Holdings How Does Yiu Kwong Sun's Compensation Compare With Similar Sized Companies?According to our data, UMP Healthcare Holdings Limited has a market capitalization of HK$1.0b, and paid its CEO total annual compensation worth HK$9.4m over the year to June 2019. We think total compensation is more important but we note that the CEO salary is lower, at HK$7.3m. We took a group of companies with market capitalizations below HK$1.6b, and calculated the median CEO total compensation to be HK$1.8m.As you can see, Yiu Kwong Sun is paid more than the median CEO pay at companies of a similar size, in the same market. However, this does not necessarily mean UMP Healthcare Holdings Limited is paying too much. A closer look at the performance of the underlying business will give us a better idea about whether the pay is particularly generous.You can see, below, how CEO compensation at UMP Healthcare Holdings has changed over time.SEHK:722 CEO Compensation, January 10th 2020MoreIs UMP Healthcare Holdings Limited Growing?Over the last three years UMP Healthcare Holdings Limited has grown its earnings per share (EPS) by an average of 2.3% per year (using a line of best fit). In the last year, its revenue is up 22%.I would argue that the modest growth in revenue is a notable positive. And the modest growth in earnings per share isn't bad, either. So while performance isn't amazing, we think it really does seem quite respectable. We don't have analyst forecasts, but you might want to assess this data-rich visualization of earnings, revenue and cash flow.Has UMP Healthcare Holdings Limited Been A Good Investment?With a total shareholder return of 1.7% over three years, UMP Healthcare Holdings Limited has done okay by shareholders. But they would probably prefer not to see CEO compensation far in excess of the median.In Summary...We examined the amount UMP Healthcare Holdings Limited pays its CEO, and compared it to the amount paid by similar sized companies. Our data suggests that it pays above the median CEO pay within that group.Over the last three years returns to investors have been uninspiring, and we would have liked to see stronger business growth. So it's certainly hard to argue that the CEO is modestly paid, although we don't see the remuneration as an issue. If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at UMP Healthcare Holdings.Arguably, business quality is much more important than CEO compensation levels. So check out this free list of interesting companies, that have HIGH return on equity and low debt.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoCrocs CEO explains its major turnaroundYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoSome ISS (CPH:ISS) Shareholders Have Copped A Big 57% Share Price DropSimply Wall St.What the GM strike means for the U.S. economyYahoo FinanceWhy negative interest rates are 'seriously dangerous': strategistYahoo FinanceAurora Cannabis tumbles after double downgradeYahoo Finance VideoCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoWhy We’re Not Keen On YHI International Limited’s (SGX:BPF) 3.8% Return On CapitalSimply Wall St.Loan growth will be a 'critical factor' in upcoming bank earnings: AnalystYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceU.S. airlines suspend flights over coronavirus fearsYahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance